ABT FY2025 SEC EDGAR DEF 14A #21 of 168 in industry

Abbott Laboratories CEO pay ratio

The CEO earned $24.2M in FY2025 against median worker pay of $145,528 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
IL
Filing date
2026-03-13
Industry
Chemicals & Pharmaceuticals
Industry rank
#21/168

Data updated August 2026

Subscribe to Abbott Laboratories CEO pay filing updates (RSS)

CEO-to-worker pay ratio
166:1
High (Scale: 0–1000:1)
CEO pay
$24.2M
Median worker
$145,528

Answer first

Abbott Laboratories's FY2025 CEO total of $24.2M ranks #116 of 1,423 complete filings; its 166:1 pay ratio ranks #391. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $145,528. Industry placement uses the FY2025 SIC-28 peer cohort (# 21 of 168, 88th percentile - top quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#116
$24.2M of 1,423 FY2025
Ratio rank
#391
166:1 of 1,423
Industry pct
88th
top quartile of industry peers by pay ratio

How Abbott Laboratories ranks nationally

Abbott Laboratories CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$24,157,648 Top 8% higher than 92% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). Below this entry. $17,500,000–$20,000,000: 54 companies (4%). Below this entry. $20,000,000–$22,500,000: 24 companies (2%). Below this entry. $22,500,000–$25,000,000: 34 companies (2%). This entry sits in this band. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Abbott Laboratories vs. Chemicals & Pharmaceuticals peers

CEO total pay ($24.2M) against pay ratio (166:1) for Abbott Laboratories (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both6970488.712080243.617189998.522299753.427409508.435.5:171.0:1106.5:1142.0:1177.4:1CEO total payPay ratio (CEO : median worker)Abbott Laboratories, CEO total pay: 24157648 · Pay ratio (CEO : median worker): 166:1Abbott LaboratoriesHuntsman CORP, CEO total pay: 14649600 · Pay ratio (CEO : median worker): 168:1Huntsman CORPCabot Corp, CEO total pay: 9307883 · Pay ratio (CEO : median worker): 171:1Cabot CorpAmgen Inc, CEO total pay: 24693120 · Pay ratio (CEO : median worker): 160:1Amgen IncQuidelOrtho Corp, CEO total pay: 11290664 · Pay ratio (CEO : median worker): 154:1QuidelOrtho CorpElement Solutions Inc, CEO total pay: 26480462 · Pay ratio (CEO : median worker): 153:1Element Solutions Inc
Abbott Laboratories vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Abbott Laboratories's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Abbott Laboratories

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
166:1
FY2025
vs prior FY
-11:1
from FY2024 177:1
CEO $ YoY
+6%
$24.2M latest
Filings shown
5
FY2021–2025
Abbott Laboratories CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $24.9M - $97,952 254:1 -
2022 $21.7M -13% $101,360 214:1 -40:1
2023 $23.3M +7.2% $132,152 176:1 -38:1
2024 $22.8M -2% $128,746 177:1 +1:1
2025 $24.2M +6% $145,528 166:1 -11:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1800, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
166:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$24.2M
Companies in Industry
168
vs. Industry Median
Above
#21 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Abbott Laboratories: STEEP · PEAK pay ratio

Abbott Laboratories's FY2025 ratio 166:1 ranks #21 of 168 Chemicals & Pharmaceuticals filers (88th percentile). the CEO earned 166× the median employee ($145,528) in FY2025.

Median employee $145,528 (ELITE-MED); STEEP · PEAK stamps put about 166 median-wage years per CEO year.

CEO Total Pay

$24.2M

FY2025 Summary Compensation, well above median

Pay Ratio

166:1

Elevated vs. peers

Abbott Laboratories in the higher Chemicals & Pharmaceuticals third

Abbott Laboratories's FY2025 ratio 166:1 ranks #21 of 168 Chemicals & Pharmaceuticals filers (88th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Abbott Laboratories's $24.2M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #116 and ratio rank #391 split - treat 166:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$24.2M
Median Employee Pay
$145,528
Pay Ratio
166:1
Filing Date
2026-03-13

Company Info

Ticker
ABT
CIK
1800
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
IL
View SEC filings →
SEC EDGAR DEF 14A for CIK 1800, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Abbott Laboratories's FY2025 ratio 166:1 ranks #21 of 168 Chemicals & Pharmaceuticals filers (88th percentile).

Read with Abbott Laboratories

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · PEAK · ELITE-MED.

PENN Entertainment, Inc. · PEAK

ABS(ceo_total_comp) peer at $24.1M (Δ $31K lighter vs Abbott Laboratories); EXTREME · PAR-MED vs this page's STEEP · PEAK · ELITE-MED.
Nextera Energy Inc · PEAK

ABS(ceo_total_comp) peer at $24.2M (Δ $32K heavier vs Abbott Laboratories); MID · ELITE-MED vs this page's STEEP · PEAK · ELITE-MED.
Mckesson Corp · PEAK

ABS(ceo_total_comp) peer at $24.2M (Δ $48K heavier vs Abbott Laboratories); HIGH · PAR-MED vs this page's STEEP · PEAK · ELITE-MED.
Oppenheimer Holdings Inc · PEAK

ABS(ceo_total_comp) peer at $24.0M (Δ $158K lighter vs Abbott Laboratories); MODEST · ELITE-MED vs this page's STEEP · PEAK · ELITE-MED.
Huntsman CORP (SIC 28 pole)

Huntsman CORP stamps STEEP · HEAVY nearest in-SIC by ABS(pay_ratio) to Abbott Laboratories's STEEP filing.
National dual ranks · #116/#391

Abbott Laboratories's FY2025 package sits #116 by CEO dollars and #391 by ratio under PEAK · STEEP.
Comp structure · PEAK

Abbott Laboratories's PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Abbott Laboratories (CIK 1800), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.